Zhou C - Search Results

1

LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.

Miao L, Liu HY, Zhou C, He X. Miao L, et al. Among authors: zhou c. J Exp Clin Cancer Res. 2019 Apr 2;38(1):143. doi: 10.1186/s13046-019-1149-4. J Exp Clin Cancer Res. 2019. PMID: 30940184 Free PMC article.

2

Elevated expression of hepcidin post-renal ischemia reperfusion injury.

Zhou C, He X, Xue D, Xu N. Zhou C, et al. Acta Biochim Biophys Sin (Shanghai). 2013 Apr;45(4):342-4. doi: 10.1093/abbs/gmt013. Epub 2013 Feb 24. Acta Biochim Biophys Sin (Shanghai). 2013. PMID: 23439664 Free article. No abstract available.

3

MD-miniRNA could be a more accurate biomarker for prostate cancer screening compared with serum prostate-specific antigen level.

Xue D, Zhou CX, Shi YB, Lu H, He XZ. Xue D, et al. Tumour Biol. 2015 May;36(5):3541-7. doi: 10.1007/s13277-014-2990-x. Epub 2015 Jan 5. Tumour Biol. 2015. PMID: 25557788

4

[Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication].

Ding T, He XZ, Xu XL, Xu HY, Zhou CX, Wang YJ. Ding T, et al. Zhonghua Nan Ke Xue. 2014 Dec;20(12):1090-2. Zhonghua Nan Ke Xue. 2014. PMID: 25597175 Chinese.

5

Decreased expression of ferroportin in prostate cancer.

Xue D, Zhou CX, Shi YB, Lu H, He XZ. Xue D, et al. Oncol Lett. 2015 Aug;10(2):913-916. doi: 10.3892/ol.2015.3363. Epub 2015 Jun 11. Oncol Lett. 2015. PMID: 26622594 Free PMC article.

6

Hepcidin as a Biomarker of Impaired Renal Function in Rat Models for Chronic Allograft Nephropathy.

Xue D, Zhou C, Shi Y, Lu H, He X. Xue D, et al. Among authors: zhou c. Med Sci Monit. 2016 Feb 23;22:608-16. doi: 10.12659/msm.895375. Med Sci Monit. 2016. PMID: 26907911 Free PMC article.

7

LncRNA GAS5 inhibits proliferation and progression of prostate cancer by targeting miR-103 through AKT/mTOR signaling pathway.

Xue D, Zhou C, Lu H, Xu R, Xu X, He X. Xue D, et al. Among authors: zhou c. Tumour Biol. 2016 Oct 14. doi: 10.1007/s13277-016-5429-8. Online ahead of print. Tumour Biol. 2016. PMID: 27743383 Free article.

8

Nuclear transcription factor Nrf2 suppresses prostate cancer cells growth and migration through upregulating ferroportin.

Xue D, Zhou C, Shi Y, Lu H, Xu R, He X. Xue D, et al. Among authors: zhou c. Oncotarget. 2016 Nov 29;7(48):78804-78812. doi: 10.18632/oncotarget.12860. Oncotarget. 2016. PMID: 27788496 Free PMC article.

9

Long noncoding RNA MALAT1 enhances the docetaxel resistance of prostate cancer cells via miR-145-5p-mediated regulation of AKAP12.

Xue D, Lu H, Xu HY, Zhou CX, He XZ. Xue D, et al. J Cell Mol Med. 2018 Jun;22(6):3223-3237. doi: 10.1111/jcmm.13604. Epub 2018 Apr 6. J Cell Mol Med. 2018. Retraction in: J Cell Mol Med. 2022 Feb;26(3):956. doi: 10.1111/jcmm.17181 PMID: 29633510 Free PMC article. Retracted.

10

m⁶A RNA modification modulates gene expression and cancer-related pathways in clear cell renal cell carcinoma.

Chen Y, Zhou C, Sun Y, He X, Xue D. Chen Y, et al. Among authors: zhou c. Epigenomics. 2020 Jan;12(2):87-99. doi: 10.2217/epi-2019-0182. Epub 2019 Dec 20. Epigenomics. 2020. PMID: 31856595

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,844 results

Search Page

Filters